| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,978 | 1,748 | 3,987 | 6,779 | | Cost of Revenue | 1,363 | 1,457 | 1,634 | 3,915 | | | Gross Profit | 3,615 | 291 | 2,352 | 2,863 | | | Operating Expenses | | Research Development | 341 | 386 | 248 | 612 | | Selling General and Administrative | 2,077 | 4,535 | 4,314 | 4,251 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,197 | (4,629) | (2,210) | (2,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4 | 4 | 11 | 34 | | Earnings Before Interest And Taxes | 1,201 | (4,625) | (2,199) | (1,965) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,201 | (4,625) | (2,199) | (1,965) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,201 | (4,625) | (2,199) | (1,965) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,201 | (4,625) | (2,199) | (1,965) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,201 | ($4,625) | ($2,199) | ($1,965) |
|
0.31% Nasdaq 
0.05%
Income Statement
